KEYNOTE-355 Asian subset: Pembrolizumab plus chemotherapy vs placebo plus chemotherapy for triple-negative breast cancer
Toshimi Takano,Javier Cortes,David W. Cescon,Seock-Ah Im,Mastura Md Yusof,Hiroji Iwata,Norikazu Masuda,Chiun-Sheng Huang,Chi-Feng Chung,Koichiro Tsugawa,Yeon Hee Park,Koji Matsumoto,Kenichi Inoue,Ava Kwong,Sherene Loi,Wei Fu,Wilbur Pan,Valia Karantza,Hope S. Rugo,Peter Schmid ANNALS OF ONCOLOGY（2022）
AI 理解论文
溯源树
样例
